Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination
Highlights • Preclinical retinoblastoma models derived from heavily pretreated patients are scarce. • Novel patient-derived preclinical retinoblastoma models (cell cultures in serum-free medium and orthotopic xenografts) reproduce key histologic and genetic features of paired patient biopsies. • Mol...
Gespeichert in:
Veröffentlicht in: | Cancer letters 2016-09, Vol.380 (1), p.10-19 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights • Preclinical retinoblastoma models derived from heavily pretreated patients are scarce. • Novel patient-derived preclinical retinoblastoma models (cell cultures in serum-free medium and orthotopic xenografts) reproduce key histologic and genetic features of paired patient biopsies. • Molecular method (RT-qPCR detection of CRX ) quantifies local and metastatic tumor burden with high sensitivity and specificity in the new xenografts. • Our research expands the previously available preclinical tools for translational research in retinoblastoma. |
---|---|
ISSN: | 0304-3835 1872-7980 |
DOI: | 10.1016/j.canlet.2016.06.012 |